Sleep Diagnostics Artificial Intelligence Market Report 2026

The sleep diagnostics artificial intelligence market size has grown rapidly in recent years. It will grow from $1.09 billion in 2025 to $1.31 billion in 2026 at a compound annual growth rate (CAGR) of 19.4%. The growth in the historic period can be attributed to growth in sleep disorder cases, expansion of wearable devices, rise in digital health analytics, increase in sleep lab studies, demand for faster diagnosis.

The sleep diagnostics artificial intelligence market size is expected to see rapid growth in the next few years. It will grow to $2.68 billion in 2030 at a compound annual growth rate (CAGR) of 19.7%. The growth in the forecast period can be attributed to adoption of AI clinical decision tools, expansion of remote sleep monitoring, growth in home based diagnostics, rising personalized sleep therapy, integration with digital health platforms. Major trends in the forecast period include AI based sleep stage scoring, wearable integrated sleep analytics, cloud based sleep diagnostic platforms, predictive sleep disorder models, automated polysomnography interpretation.

The rising prevalence of sleep disorders is expected to drive the growth of the sleep diagnostics artificial intelligence market in the coming years. Sleep disorders are medical conditions that disrupt normal sleep patterns, affecting the quality, timing, or duration of sleep and resulting in daytime distress or impaired functioning. Increasing prevalence is driven by factors such as aging populations, lifestyle-related stress, and heightened awareness of sleep health, which have contributed to greater screening, diagnosis, and reporting. Sleep diagnostics artificial intelligence addresses sleep disorders by enabling automated, accurate, and scalable analysis of sleep data, supporting early detection, personalized treatment, and improved clinical outcomes. For instance, in November 2023, NHS England reported that 64.9% of young people aged 17 to 23 experienced sleep problems three or more times in the previous week, highlighting a growing burden of sleep-related issues and rising demand for diagnostic solutions. Therefore, the increasing prevalence of sleep disorders represents a key driver of growth in the sleep diagnostics artificial intelligence market.

Key companies operating in the sleep diagnostics artificial intelligence market are focusing on technological enhancements in automated sleep scoring to reduce clinician dependency and diagnostic variability, such as frictionless sleep monitoring technology, to gain a competitive advantage. Frictionless sleep monitoring technology refers to a contactless, AI-powered system that automatically captures and analyzes sleep patterns, stages, and disturbances without requiring wearable devices, enabling accurate and convenient sleep diagnostics. For example, in December 2025, Sleep.ai, a U.S.-based digital health company, launched Sleep Sense, a frictionless sleep monitoring technology that turns any smartphone into a privacy-aware sleep sensor, enabling near-universal sleep data capture without wearables or manual input. It uses advanced AI boundary detection with hybrid spatio-temporal models to accurately identify bedtime and wake time, comparable to PSG-validated trackers. Through multimodal contextual modeling, it analyzes signals such as motion, ambient light, and device usage patterns to generate reliable sleep insights even when data is noisy or limited.

In July 2023, ResMed, a US-based provider of cloud-connected medical devices and digital health solutions for respiratory care and sleep disorders, acquired Somnoware for an undisclosed amount. Through this acquisition, ResMed sought to enhance its sleep diagnostics ecosystem by integrating Somnoware’s advanced digital diagnostic and workflow software to improve efficiency and interoperability for sleep labs and clinicians. Somnoware is a US-based provider of digital sleep and respiratory care diagnostics software, offering solutions that streamline diagnostic processes, test result management, and patient care coordination within sleep medicine practices.

Major companies operating in the sleep diagnostics artificial intelligence market are ResMed Inc., Neurosoft Ltd., Nox Health Inc., Itamar Medical Ltd., Compumedics Limited, Beacon Biosignals Inc., Onera Health Inc., EnsoData Inc., SleepImage Inc., Zeto Inc., HoneyNaps Co. Ltd., SOMNOmedics GmbH, SleepScore Labs, Nox Medical A/S, Sleep.AI Inc., Sleepacta S.r.l.

Tariffs are influencing the sleep diagnostics artificial intelligence market by increasing the cost of imported monitoring hardware, wearable sensors, and diagnostic devices. Higher duties are raising deployment costs for AI enabled sleep testing systems and integrated platforms. Hardware dependent segments such as wearable and in lab monitoring are most affected. Regions relying on imported medical electronics, especially in asia pacific and europe, are facing higher acquisition costs. Vendors are shifting toward software focused offerings and regional device sourcing. Tariffs are also encouraging domestic manufacturing of sleep monitoring hardware. This strengthens local digital health device ecosystems and supply resilience.

The sleep diagnostics artificial intelligence market research report is one of a series of new reports that provides sleep diagnostics artificial intelligence market statistics, including sleep diagnostics artificial intelligence industry global market size, regional shares, competitors with a sleep diagnostics artificial intelligence market share, detailed sleep diagnostics artificial intelligence market segments, market trends and opportunities, and any further data you may need to thrive in the sleep diagnostics artificial intelligence industry. This sleep diagnostics artificial intelligence market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Sleep diagnostics artificial intelligence (AI) includes AI-powered technologies that analyze sleep-related data from wearable devices, medical equipment, and clinical studies to identify and evaluate sleep disorders. It examines patterns such as sleep phases, breathing activity, movement, and heart rate to support accurate diagnosis. It helps healthcare providers improve diagnostic precision, tailor treatments, and enhance patient outcomes.

The primary components of sleep diagnostics artificial intelligence include software, hardware, and services. Software refers to platforms that evaluate sleep-related data and health indicators using artificial intelligence technologies. These solutions use machine learning, deep learning, natural language processing, ensemble learning, and other approaches, and are deployed through cloud-based or on-premises environments. The applications include sleep apnea, insomnia, narcolepsy, restless legs syndrome, circadian rhythm disorders, and other conditions. The end users include hospitals, sleep clinics and centers, home care environments, research institutions, and others.

The sleep diagnostics artificial intelligence (AI) market consists of revenues earned by entities by providing services such as sleep data analysis and interpretation, remote patient monitoring, personalized sleep assessment and reporting, clinical decision support, predictive analytics for sleep health, and ongoing system support and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The sleep diagnostics artificial intelligence (AI) market includes sales of diagnostic algorithms and models, sleep monitoring platforms, wearable device integration tools, clinical decision support systems, data analytics dashboards. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, distributors, and retailers) or directly to customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.